Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis

NCT00004482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myocarditis
Giant Cell Myocarditis

Interventions

DRUG: Cyclosporine
DRUG: methylprednisolone
DRUG: Muromonab-CD3
DRUG: prednisone

Sponsor

Mayo Clinic